Skip to main content

and
  1. Article

    Open Access

    Effect on cardiac function among patients with type 2 diabetes following high-dose mineralocorticoid receptor antagonist using echocardiography; data from the MIRAD randomized clinical trial

    Early heart failure prevention is central in patients with type 2 diabetes, and mineralocorticoid receptor antagonists (MRAs) have shown to improve prognosis. We investigated the effect of high-dose MRA, epler...

    Niels H. Brandt-Jacobsen, Marie Louise Johansen in BMC Cardiovascular Disorders (2023)

  2. No Access

    Article

    Effect of empagliflozin on myocardial structure and function in patients with type 2 diabetes at high cardiovascular risk: the SIMPLE randomized clinical trial

    To investigate the effects of 13 weeks treatment with empagliflozin in patients with high-risk type-2 diabetes mellitus on echocardiographic measures of left ventricular (LV) structure and function compared to...

    Mads Ersbøll, Mikkel Jürgens, Philip Hasbak in The International Journal of Cardiovascula… (2022)